Kim, Jung-Hyun; Villanueva, Laura; Zell, Claudia; Sinninghe Damsté, Jaap S (2017): (Appendix 6) Concentrations of CL and IPL-derived isoGDGTs normalized to OC and BIT values for marine surface sediments [dataset]. PANGAEA, https://doi.org/10.1594/PANGAEA.878907, In supplement to: Kim, J-H et al. (2016): Biological source and provenance of deep-water derived isoprenoid tetraether lipids along the Portuguese continental margin. Geochimica et Cosmochimica Acta, 172, 177-204, https://doi.org/10.1016/j.gca.2015.09.010
Always quote citation above when using data! You can download the citation in several formats below.
Project(s):
Coverage:
Median Latitude: 39.503452 * Median Longitude: -9.444710 * South-bound Latitude: 38.226000 * West-bound Longitude: -10.216000 * North-bound Latitude: 41.243000 * East-bound Longitude: -8.695000
Date/Time Start: 2011-03-14T14:08:00 * Date/Time End: 2011-03-28T16:39:00
Minimum DEPTH, sediment/rock: 0 m * Maximum DEPTH, sediment/rock: 0 m
Event(s):
64PE332-1_3 * Latitude: 41.134000 * Longitude: -8.695000 * Date/Time: 2011-03-14T14:08:00 * Elevation: -15.3 m * Location: Portuguese Margin * Campaign: 64PE332 (Pacemaker) * Basis: Pelagia * Method/Device: MultiCorer (MUC)
Parameter(s):
License:
Creative Commons Attribution 3.0 Unported (CC-BY-3.0)
Size:
612 data points
Data
1 Event | 2 Area | 3 Depth sed [m] | 4 Samp type (fraction) | 5 Method comm (extraction techniques: ASE = ...) | 6 iso GDGT/TOC [µg/g] (C1302) | 7 iso GDGT/TOC [µg/g] (C1300) | 8 iso GDGT/TOC [µg/g] (C1298) | 9 iso GDGT/TOC [µg/g] (C1296) | 10 iso GDGT/TOC [µg/g] (C1292) | 11 iso GDGT/TOC [µg/g] (C1292') | 12 iso GDGT/TOC [µg/g] (Sum of all 6 CL isoGDGTs) | 13 iso GDGT/TOC [µg/g] (Sum of 4 CL isoGDGTs) | 14 BIT |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
64PE332-1_3 | I. Douro transect | 0 | core lipid | ASE | 198 | 21.0 | 9.0 | 4.0 | 175 | 3.0 | 410 | 36 | 0.12 |
64PE332-7_2 | I. Douro transect | 0 | core lipid | ASE | 486 | 49.0 | 25.0 | 11.0 | 465 | 8.0 | 1043 | 93 | 0.06 |
64PE332-7_2 | I. Douro transect | 0 | core lipid | BD | 297 | 31.0 | 15.0 | 7.0 | 301 | 5.0 | 656 | 58 | 0.05 |
64PE332-7_2 | I. Douro transect | 0 | IPL-derived fractions | BD | 25 | 4.0 | 3.0 | 1.0 | 15 | 1.0 | 48 | 8 | 0.11 |
64PE332-9_1 | I. Douro transect | 0 | core lipid | ASE | 243 | 34.0 | 19.0 | 8.0 | 364 | 7.0 | 675 | 68 | 0.03 |
64PE332-6_1 | I. Douro transect | 0 | core lipid | ASE | 285 | 38.0 | 20.0 | 8.0 | 309 | 10.0 | 670 | 76 | 0.04 |
64PE332-6_1 | I. Douro transect | 0 | core lipid | BD | 153 | 20.0 | 11.0 | 4.0 | 174 | 4.0 | 366 | 39 | 0.04 |
64PE332-6_1 | I. Douro transect | 0 | IPL-derived fractions | BD | 10 | 2.0 | 2.0 | 1.0 | 7 | 1.0 | 22 | 5 | 0.13 |
64PE332-5_2 | I. Douro transect | 0 | core lipid | ASE | 307 | 52.0 | 36.0 | 9.0 | 364 | 16.0 | 784 | 113 | 0.02 |
64PE332-5_2 | I. Douro transect | 0 | core lipid | BD | 118 | 22.0 | 15.0 | 4.0 | 149 | 0.2 | 308 | 41 | 0.01 |
64PE332-5_2 | I. Douro transect | 0 | IPL-derived fractions | BD | 11 | 3.0 | 2.0 | 1.0 | 11 | 1.0 | 28 | 6 | 0.03 |
64PE332-4_1 | I. Douro transect | 0 | core lipid | ASE | 163 | 33.0 | 30.0 | 5.0 | 230 | 13.0 | 473 | 81 | 0.02 |
64PE332-4_1 | I. Douro transect | 0 | core lipid | BD | 43 | 9.0 | 8.0 | 1.0 | 61 | 3.0 | 125 | 21 | 0.02 |
64PE332-4_1 | I. Douro transect | 0 | IPL-derived fractions | BD | 4 | 1.0 | 1.0 | 0.2 | 4 | 0.3 | 10 | 2 | 0.03 |
64PE332-3_7 | I. Douro transect | 0 | core lipid | ASE | 197 | 44.0 | 48.0 | 5.0 | 285 | 19.0 | 599 | 116 | 0.01 |
64PE332-3_7 | I. Douro transect | 0 | core lipid | BD | 92 | 21.0 | 23.0 | 3.0 | 136 | 9.0 | 284 | 56 | 0.01 |
64PE332-3_7 | I. Douro transect | 0 | IPL-derived fractions | BD | 8 | 1.0 | 2.0 | 0.3 | 7 | 1.0 | 19 | 4 | 0.01 |
64PE332-11_2 | II. Mondego transect | 0 | core lipid | ASE | 488 | 49.0 | 23.0 | 10.0 | 454 | 7.0 | 1030 | 88 | 0.05 |
64PE332-12_1 | II. Mondego transect | 0 | core lipid | ASE | 596 | 89.0 | 47.0 | 20.0 | 898 | 16.0 | 1667 | 172 | 0.02 |
64PE332-13_3 | II. Mondego transect | 0 | core lipid | ASE | 513 | 101.0 | 78.0 | 17.0 | 715 | 31.0 | 1455 | 227 | 0.01 |
64PE332-14_4 | II. Mondego transect | 0 | core lipid | ASE | 141 | 33.0 | 33.0 | 5.0 | 230 | 15.0 | 457 | 85 | 0.01 |
64PE332-15_1 | II. Mondego transect | 0 | core lipid | ASE | 278 | 65.0 | 71.0 | 8.0 | 426 | 30.0 | 880 | 175 | 0.01 |
64PE332-24_2 | III. Estremadura transect | 0 | core lipid | ASE | 656 | 85.0 | 42.0 | 17.0 | 694 | 11.0 | 1505 | 155 | 0.02 |
64PE332-17_2 | III. Estremadura transect | 0 | core lipid | ASE | 700 | 91.0 | 44.0 | 19.0 | 733 | 12.0 | 1599 | 166 | 0.03 |
64PE332-18_5 | III. Estremadura transect | 0 | core lipid | ASE | 444 | 65.0 | 36.0 | 15.0 | 565 | 17.0 | 1142 | 132 | 0.02 |
64PE332-25_2 | III. Estremadura transect | 0 | core lipid | ASE | 457 | 67.0 | 35.0 | 14.0 | 562 | 19.0 | 1155 | 135 | 0.02 |
64PE332-26_2 | III. Estremadura transect | 0 | core lipid | ASE | 993 | 169.0 | 110.0 | 33.0 | 1251 | 40.0 | 2597 | 353 | 0.01 |
64PE332-20_2 | III. Estremadura transect | 0 | core lipid | ASE | 291 | 53.0 | 37.0 | 10.0 | 404 | 15.0 | 811 | 115 | 0.01 |
64PE332-22_6 | III. Estremadura transect | 0 | core lipid | ASE | 211 | 50.0 | 51.0 | 7.0 | 322 | 20.0 | 662 | 129 | 0.01 |
64PE332-23_2 | III. Estremadura transect | 0 | core lipid | ASE | 206 | 46.0 | 51.0 | 6.0 | 309 | 25.0 | 643 | 128 | 0.01 |
64PE332-27_3 | IV. Tagus transect | 0 | core lipid | ASE | 181 | 18.0 | 9.0 | 4.0 | 168 | 3.0 | 382 | 34 | 0.15 |
64PE332-27_3 | IV. Tagus transect | 0 | core lipid | BD | 344 | 36.0 | 18.0 | 7.0 | 349 | 5.0 | 758 | 66 | 0.16 |
64PE332-27_3 | IV. Tagus transect | 0 | IPL-derived fractions | BD | 80 | 11.0 | 7.0 | 3.0 | 43 | 2.0 | 146 | 22 | 0.17 |
64PE332-29_2 | IV. Tagus transect | 0 | core lipid | ASE | 364 | 39.0 | 19.0 | 8.0 | 373 | 6.0 | 809 | 72 | 0.07 |
64PE332-29_2 | IV. Tagus transect | 0 | core lipid | BD | 92 | 10.0 | 5.0 | 2.0 | 95 | 1.0 | 205 | 18 | 0.08 |
64PE332-29_2 | IV. Tagus transect | 0 | IPL-derived fractions | BD | 15 | 3.0 | 2.0 | 1.0 | 10 | 0.4 | 30 | 5 | 0.11 |
64PE332-30_1 | IV. Tagus transect | 0 | core lipid | ASE | 271 | 35.0 | 19.0 | 8.0 | 325 | 8.0 | 666 | 70 | 0.05 |
64PE332-28_1 | IV. Tagus transect | 0 | core lipid | ASE | 150 | 17.0 | 9.0 | 4.0 | 171 | 4.0 | 355 | 34 | 0.07 |
64PE332-28_1 | IV. Tagus transect | 0 | core lipid | BD | 151 | 17.0 | 9.0 | 4.0 | 175 | 3.0 | 359 | 33 | 0.07 |
64PE332-28_1 | IV. Tagus transect | 0 | IPL-derived fractions | BD | 19 | 4.0 | 3.0 | 1.0 | 11 | 1.0 | 38 | 8 | 0.15 |
64PE332-31_2 | IV. Tagus transect | 0 | core lipid | ASE | 370 | 64.0 | 47.0 | 12.0 | 505 | 20.0 | 1018 | 143 | 0.02 |
64PE332-31_2 | IV. Tagus transect | 0 | core lipid | BD | 19 | 3.0 | 2.0 | 1.0 | 26 | 1.0 | 52 | 7 | 0.02 |
64PE332-31_2 | IV. Tagus transect | 0 | IPL-derived fractions | BD | 2 | 0.4 | 0.4 | 0.1 | 1 | 0.1 | 4 | 1 | 0.05 |
64PE332-33_1 | IV. Tagus transect | 0 | core lipid | ASE | 277 | 58.0 | 49.0 | 9.0 | 403 | 24.0 | 819 | 140 | 0.02 |
64PE332-33_1 | IV. Tagus transect | 0 | core lipid | BD | 28 | 6.0 | 5.0 | 1.0 | 41 | 2.0 | 82 | 14 | 0.02 |
64PE332-33_1 | IV. Tagus transect | 0 | IPL-derived fractions | BD | 3 | 1.0 | 1.0 | 0.2 | 3 | 0.3 | 8 | 2 | 0.04 |
64PE332-36_3 | IV. Tagus transect | 0 | core lipid | ASE | 177 | 38.0 | 38.0 | 5.0 | 269 | 20.0 | 547 | 102 | 0.03 |
64PE332-34_2 | V. Sado transect | 0 | core lipid | ASE | 120 | 15.0 | 8.0 | 3.0 | 151 | 3.0 | 300 | 29 | 0.08 |
64PE332-38_2 | V. Sado transect | 0 | core lipid | ASE | 444 | 59.0 | 34.0 | 13.0 | 523 | 13.0 | 1085 | 119 | 0.04 |
64PE332-37_2 | V. Sado transect | 0 | core lipid | ASE | 244 | 41.0 | 30.0 | 7.0 | 326 | 13.0 | 662 | 92 | 0.02 |
64PE332-40_1 | V. Sado transect | 0 | core lipid | ASE | 249 | 52.0 | 47.0 | 8.0 | 367 | 23.0 | 746 | 130 | 0.02 |